a decreasing trendP = 0.12
Our results demonstrated that treatment with cabergoline decreased 2-h insulin level (P = 0.02), and showed a decreasing trend in fasting insulin level (P = 0.12) ( 29 ).
Our results demonstrated that treatment with cabergoline decreased 2-h insulin level (P = 0.02), and showed a decreasing trend in fasting insulin level (P = 0.12) ( 29 ).
In the present study, FPG, 2-h-PG, 2-h insulin, HOMA2 %S, and HOMA2 IR showed significant improvement, and changes in other factors showed a positive trend.
The trend of non-significant A1c changes was decreasing in the cabergoline group versus an increasing trend in the placebo group.